Skip to main content
logo
Entheon Biomedical Corp. (CSE:ENBI.X)
Canada flag Canada · Delayed Price · Currency is CAD
0.0600
0.00 (0.00%)
At close: Sep 2, 2026

Entheon Biomedical Ratios and Metrics

Millions CAD. Fiscal year is Dec - Nov.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Market Capitalization
1111232
Market Cap Growth
-36.84%17.33%109.89%-66.67%-94.44%3.86%
Enterprise Value
1110228
Last Close Price
0.060.100.140.100.305.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
PS Ratio
---2.369.35-
PB Ratio
1.734.498.531.872.883.52
P/TBV Ratio
1.734.498.531.872.8810.13

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
EV/Sales Ratio
---0.848.04-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Net Debt / Equity Ratio
-0.68-0.99-0.94-1.09-1.11-0.23
Net Debt / EBITDA Ratio
----0.190.25
Net Debt / FCF Ratio
3.811.020.380.960.350.38
Asset Turnover
---0.430.04-
Quick Ratio
11.8411.103.544.114.672.24
Current Ratio
12.1711.724.534.644.813.46
Return on Equity (ROE)
9.47%-138.07%-137.90%-64.49%-42.66%-125.03%
Return on Assets (ROA)
-41.05%-77.52%-70.93%-33.41%-41.88%-71.06%
Return on Capital Employed (ROCE)
-66.70%-103.10%-228.90%-99.10%-585.80%-90.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Earnings Yield
5.21%-22.27%-25.63%-50.77%-480.67%-27.87%
FCF Yield
-10.23%-21.62%-28.68%-60.91%-110.26%-16.72%
Buyback Yield / Dilution
-27.09%-73.25%-30.96%--8.85%-97.83%